Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 164

1.

Biomechanical and electromyogram characterization of neuroleptic-induced rigidity in the rat.

Wu YN, Hyland BI, Chen JJ.

Neuroscience. 2007 Jun 15;147(1):183-96. Epub 2007 May 15.

PMID:
17507166
2.

SCH 58261, an A(2A) adenosine receptor antagonist, counteracts parkinsonian-like muscle rigidity in rats.

Wardas J, Konieczny J, Lorenc-Koci E.

Synapse. 2001 Aug;41(2):160-71.

PMID:
11400182
3.

Time course quantification of spastic hypertonia following spinal hemisection in rats.

Hsieh TH, Tsai JY, Wu YN, Hwang IS, Chen TI, Chen JJ.

Neuroscience. 2010 Apr 28;167(1):185-98. doi: 10.1016/j.neuroscience.2010.01.064. Epub 2010 Feb 8.

PMID:
20149848
4.

L-701,324, a selective antagonist at the glycine site of the NMDA receptor, counteracts haloperidol-induced muscle rigidity in rats.

Konieczny J, Ossowska K, Schulze G, Coper H, Wolfarth S.

Psychopharmacology (Berl). 1999 Apr;143(3):235-43.

PMID:
10353425
5.

Regulation of hind-limb tone by adenosine A2A receptor in rats.

Wu YN, Chen JJ, Zhang LQ, Hyland BI.

Neuroscience. 2009 Apr 10;159(4):1408-13. doi: 10.1016/j.neuroscience.2009.01.068. Epub 2009 Feb 4.

PMID:
19409216
6.
9.

An animal model of extrapyramidal side effects induced by antipsychotic drugs: relationship with D2 dopamine receptor occupancy.

Crocker AD, Hemsley KM.

Prog Neuropsychopharmacol Biol Psychiatry. 2001 Apr;25(3):573-90.

PMID:
11370998
10.
11.
13.

Atipamezole, an alpha 2 antagonist, augments opiate-induced muscle rigidity in the rat.

Weinger MB, Bednarczyk JM.

Pharmacol Biochem Behav. 1994 Nov;49(3):523-9.

PMID:
7862703
14.

Quantitative measurement of trunk rigidity in parkinsonian patients.

Mak MK, Wong EC, Hui-Chan CW.

J Neurol. 2007 Feb;254(2):202-9. Epub 2007 Mar 2.

PMID:
17334954
15.

A novel method for systematic analysis of rigidity in Parkinson's disease.

Endo T, Okuno R, Yokoe M, Akazawa K, Sakoda S.

Mov Disord. 2009 Nov 15;24(15):2218-24. doi: 10.1002/mds.22752.

PMID:
19768729
16.

Does reserpine induce parkinsonian rigidity?

Lorenc-Koci E, Ossowska K, Wardas J, Wolfarth S.

J Neural Transm Park Dis Dement Sect. 1995;9(2-3):211-23.

PMID:
8527005
17.

Atropine reduces raclopride-induced muscle rigidity by acting in the ventral region of the striatum.

Hemsley KM, Crocker AD.

Eur J Pharmacol. 2002 Jan 11;434(3):117-23.

PMID:
11779574
18.

Muscular rigidity and delineation of a dopamine-specific neostriatal subregion: tonic EMG activity in rats.

Ellenbroek B, Schwarz M, Sontag KH, Jaspers R, Cools A.

Brain Res. 1985 Oct 14;345(1):132-40.

PMID:
2998546
20.

Myometry revealed medication-induced decrease in resting skeletal muscle stiffness in Parkinson's disease patients.

Marusiak J, Jaskólska A, Koszewicz M, Budrewicz S, Jaskólski A.

Clin Biomech (Bristol, Avon). 2012 Jul;27(6):632-5. doi: 10.1016/j.clinbiomech.2012.02.001. Epub 2012 Feb 25.

PMID:
22365901

Supplemental Content

Support Center